March 24th, 2022
Session 1:
"What is Good Enough Myocardial Repair, Recovery or Remission in Chronic HF?"
Chairs:
James Fang, MD
Karen May-Newman, PhD
Robin Shaw, MD, PhD
1. @ 15 - Biomedical Engineering Perspective - James Antaki, PhD
2. @ 44 - Clinical Perspective - Clyde Yancy, MD
3. @ 01:06 - Basic Science Perspective - Florian Weinberger, MD
Keynote Address @ 1:42:
"Recovery From What?"
Lynne Warner Stevenson, MD
Session 3:
"Innovation in Heart Failure & Myocardial Recovery"
Chairs:
Kirk Knowlton, MD
TinTing Hong, PhD
Omar Wever-Pinzon, MD
1. @ 2:53 - PKG takes a Left Turn - New Stuff this Kinase Can Do - David Kass, MD
2. @ 3:20 - Exploiting Cardiac Cell Surface Glycoproteins for Precision Medicine - Rebekah Gundry, PhD
3. @ 3:46 - Transcriptional Regulation of Cardiomyocyte Renewal: From Mechanism to Therapeutics - Hesham Sadek, MD, PhD
4. @ 4:10 - Immaturity of Cardiomyocytes and Change of Bone Marrow Induced Heart Failure - Issei Komuro, MD, PhD
5. @ 4:39 - The Inflammation Hypothesis and HF Therapeutics: How does a Real Comeback Look Like? - Antonio Abbate, MD
Session 4:
"Innovation in Myocardial Metabolism"
Chairs:
Jared Rutter, PhD
Sihem Boudina, PhD
Scott Summers, PhD
1. @ 5:09 - Mitochondrial Metabolites in Cardiac Ischemia Reperfusion Injury - Michael P. Murphy, PhD
2. @ 5:38 - Novel Mitochondrial Mechanism - Rong Tian, MD
3. @6:01 - Cardiac Mitochondrial Ca2+: How it is Regulated and its Role in Cardiovascular Function and Disease - Elizabeth Murphy, PhD
4. @ 6:28 - Glucose Metabolism and Heart Failure - Dale Abel, MD, PhD